Works matching IS 10837159 AND DT 2022 AND VI 27 AND IP 5

Results: 22

Stepping Down, Looking Forward.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 335, doi. 10.1093/oncolo/oyac073

By:

Chabner, Bruce A

Publication type:

Article

Call for Adoption of Synchronized Biweekly Dosing of Anti-EGFR Agent Cetuximab: Implications for Patients with Metastatic Colorectal Cancer, and Squamous Cell Carcinoma of the Head and Neck.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 336, doi. 10.1093/oncolo/oyac070

By:

Kasi, Pashtoon Murtaza

Publication type:

Article

In Reply.

Published in:

2022

By:

Rai, Karan;
Brooks, Gabriel

Publication type:

Letter to the Editor

Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping.

Published in:

2022

By:

Morelli, Cristina;
Formica, Vincenzo;
Doldo, Elena;
Riondino, Silvia;
Rofei, Michela;
Vergilii, Lorena;
Palmieri, Giampiero;
Arkenau, Hendrik-Tobias;
Roselli, Mario;
Orlandi, Augusto

Publication type:

Letter to the Editor

Incidence, Clinical Characteristics, and Predictors of Cardiovascular Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.

Published in:

Oncologist, 2022, v. 27, n. 5, p. e410, doi. 10.1093/oncolo/oyac056

By:

Isawa, Tsuyoshi;
Toi, Yukihiro;
Sugawara, Shunichi;
Taguri, Masataka;
Toyoda, Shigeru

Publication type:

Article

Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 344, doi. 10.1093/oncolo/oyac050

By:

Shafaee, Maryam Nemati;
Silva, Leonardo Roberto;
Ramalho, Susana;
Doria, Maira Teixeira;
Natal, Rodrigo De Andrade;
Cabello, Victor;
Cons, Livia;
Pavanello, Marina;
Zeferino, Luiz Carlos;
Mano, Max S;
Linck, Rudinei Diogo Marques;
Batista, Leticia Souza;
Pedro, Estela Pantarotto;
Paula, Bruno Henrique De;
Zuca-Matthes, Gustavo;
Podany, Emily;
Makawita, Shalini;
Stewart, Kelsey Ann;
Tsavachidis, Spiridon;
Tamimi, Rull

Publication type:

Article

Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 352, doi. 10.1093/oncolo/oyac047

By:

Rensburg, Helena J Janse van;
Spiliopoulou, Pavlina;
Siu, Lillian L

Publication type:

Article

On Crying.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 424, doi. 10.1093/oncolo/oyac043

By:

Sanft, Tara

Publication type:

Article

"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.

Published in:

Oncologist, 2022, v. 27, n. 5, p. e393, doi. 10.1093/oncolo/oyac039

By:

Shickh, Salma;
Oldfield, Leslie E;
Clausen, Marc;
Mighton, Chloe;
Sebastian, Agnes;
Calvo, Alessia;
Baxter, Nancy N;
Dawson, Lesa;
Penney, Lynette S;
Foulkes, William;
Basik, Mark;
Sun, Sophie;
Schrader, Kasmintan A;
Regier, Dean A;
Karsan, Aly;
Pollett, Aaron;
Pugh, Trevor J;
Kim, Raymond H;
Bombard, Yvonne;
Consortium, CHARM

Publication type:

Article

COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 398, doi. 10.1093/oncolo/oyac038

By:

Borno, Hala T;
Kim, Mi-Ok;
Hong, Julian C;
Yousefi, Sasha;
Lin, Amy;
Tolstykh, Irina;
Zhang, Sylvia;
McKay, Rana R;
Harismendy, Olivier;
Cinar, Pelin;
Rugo, Hope;
Koshkin, Vadim S;
Rabow, Maya;
Wang, Christine;
Bailey, Adina;
Small, Eric J

Publication type:

Article

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 414, doi. 10.1093/oncolo/oyac023

By:

Garnier, Louis;
Vidal, Chrystelle;
Chinot, Olivier;
Moyal, Elisabeth Cohen-Jonathan;
Djelad, Apolline;
Bronnimann, Charlotte;
Bekaert, Lien;
Taillandier, Luc;
Frenel, Jean-Sébastien;
Langlois, Olivier;
Colin, Philippe;
Menei, Philippe;
Dhermain, Frédéric;
Carpentier, Catherine;
Gerazime, Aurélie;
Curtit, Elsa;
Figarella-Branger, Dominique;
Dehais, Caroline;
Ducray, François

Publication type:

Article

Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 389, doi. 10.1093/oncolo/oyac034

By:

Park, Hyo Jung;
Qin, Lei;
Bakouny, Ziad;
Krajewski, Katherine M;
Allen, Eliezer M Van;
Choueiri, Toni K;
Shinagare, Atul B

Publication type:

Article

Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms.

Published in:

Oncologist, 2022, v. 27, n. 5, p. e402, doi. 10.1093/oncolo/oyac033

By:

Rhee, John Y;
Torun, Nurhan;
Neilan, Tomas G;
Guidon, Amanda C

Publication type:

Article

Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 363, doi. 10.1093/oncolo/oyac030

By:

Siembida, Elizabeth J;
Loomans-Kropp, Holli A;
Tami-Maury, Irene;
Freyer, David R;
Sung, Lillian;
Crosswell, Howland E;
Pollock, Brad H;
Roth, Michael E

Publication type:

Article

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 380, doi. 10.1093/oncolo/oyac025

By:

Kim, Jin K;
Marco, Michael R;
Roxburgh, Campbell S D;
Chen, Chin-Tung;
Cercek, Andrea;
Strombom, Paul;
Temple, Larissa K F;
Nash, Garrett M;
Guillem, Jose G;
Paty, Philip B;
Yaeger, Rona;
Stadler, Zsofia K;
Gonen, Mithat;
Segal, Neil H;
Reidy, Diane L;
Varghese, Anna;
Shia, Jinru;
Vakiani, Efsevia;
Wu, Abraham J;
Romesser, Paul B

Publication type:

Article

Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.

Published in:

Oncologist, 2022, v. 27, n. 5, p. e406, doi. 10.1093/oncolo/oyac037

By:

Ravi, Praful;
Ravi, Arvind;
Riaz, Irbaz B;
Freeman, Dory;
Curran, Catherine;
Mantia, Charlene;
McGregor, Bradley A;
Kilbridge, Kerry L;
Pan, Chong-Xian;
Pek, Michelle;
Choudhury, Yukti;
Tan, Min-Han;
Sonpavde, Guru P

Publication type:

Article

Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 407, doi. 10.1093/oncolo/oyac021

By:

Lemmon, Christopher A;
Zabor, Emily C;
Pennell, Nathan A

Publication type:

Article

Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot Skin Reaction: A Single-Arm, Open-Label Phase I/II Study (DGA Study).

Published in:

Oncologist, 2022, v. 27, n. 5, p. e384, doi. 10.1093/oncolo/oyab067

By:

Yamamoto, Kazuhiro;
Nishiyama, Satoshi;
Kunisada, Makoto;
Iida, Masashi;
Ito, Takahiro;
Ioroi, Takeshi;
Makimoto, Hiroo;
Omura, Tomohiro;
Harada, Kenichi;
Fujisawa, Masato;
Nishigori, Chikako;
Yano, Ikuko

Publication type:

Article

Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Efficacy, and Biomarkers.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 342, doi. 10.1093/oncolo/oyab066

By:

Wang, Yakun;
Liu, Tianshu;
Chen, Gongyan;
Gong, Jifang;
Bai, Yuxian;
Zhang, Tao;
Xu, Nong;
Liu, Li;
Xu, Jianming;
He, Jianxing;
Liu, Yunpeng;
Zhang, Li;
Jiang, Da;
Wang, Mengzhao;
Chang, Jianhua;
Li, Wei;
Bai, Chunmei;
Zhou, Jinghong;
Wang, Jian;
Ren, Yongxin

Publication type:

Article

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).

Published in:

Oncologist, 2022, v. 27, n. 5, p. 338, doi. 10.1093/oncolo/oyab065

By:

Sideras, Kostandinos;
Hillman, David W;
Giridhar, Karthik;
Ginos, Brenda F;
Tenglin, Richard C;
Liu, Heshan;
Chen, Beiyun;
Tan, Winston;
Gross, Gerald G;
Mowat, Rex B;
Dueck, Amylou C;
Perez, Edith A;
Moreno-Aspitia, Alvaro

Publication type:

Article

Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201).

Published in:

Oncologist, 2022, v. 27, n. 5, p. 340, doi. 10.1093/oncolo/oyab062

By:

Kawamoto, Yasuyuki;
Yuki, Satoshi;
Meguro, Takashi;
Hatanaka, Kazuteru;
Uebayashi, Minoru;
Nakamura, Michio;
Okuda, Hiroyuki;
Iwanaga, Ichiro;
Kato, Takashi;
Nakano, Shintaro;
Sato, Atsushi;
Harada, Kazuaki;
Oba, Koji;
Sakata, Yuh;
Sakamoto, Naoya;
Komatsu, Yoshito

Publication type:

Article

Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis.

Published in:

Oncologist, 2022, v. 27, n. 5, p. 371, doi. 10.1093/oncolo/oyab030

By:

Parikh, Aparna R;
Gonzalez-Gugel, Elena;
Smolyakova, Natalia;
Jen, Min-Hua;
Toms, Nikki;
Lin, Yong;
Kim, Jong Seok;
Kopetz, Scott

Publication type:

Article